跳至主要内容
临床试验/NCT06815406
NCT06815406招募中不适用

Recurrence Rate After Endoscopic Resection of , Laterally Spreading Tumor Granular Type (LST-G) of the Colon and Rectum: Endoscopic Mucosal Resection (EMR) vs. Endoscopic Submucosal Dissection (ESD): A Multicenter Randomized Controlled Trial ( ESD vs EMR )

Azienda USL Reggio Emilia - IRCCS5 个研究点 分布在 1 个国家目标入组 282 人开始时间: 2021年11月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
282
试验地点
5
主要终点
Recurrence/Adenomatous Residual Rate

研究概览

简要总结

Colorectal cancer is one of the leading causes of cancer-related mortality worldwide. Early-stage non-polypoid neoplastic lesions, particularly Laterally Spreading Tumors - Granular Type (LST-G) larger than 20mm, require effective endoscopic removal to prevent malignant progression. The two primary techniques for resecting these lesions are Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD).

EMR is a widely used, minimally invasive technique that involves resecting the lesion with a diathermic snare after submucosal injection. While effective and safe, EMR often necessitates piecemeal resection, increasing the risk of local recurrence. In contrast, ESD, developed in Asia, allows for en bloc resection regardless of lesion size, ensuring more accurate histopathological assessment and lower recurrence rates. However, ESD requires greater technical expertise, has longer procedural times, and carries a higher risk of complications.

In Western clinical practice, EMR remains the standard treatment, whereas ESD is selectively performed in high-expertise centers. Given the lack of randomized controlled trials comparing EMR and ESD in Western populations, this study aims to provide robust clinical evidence to guide treatment decisions.

The primary objective of this study is to compare the recurrence/residual adenomatous tissue rate at 6 and 12 months between EMR and ESD in patients with LST-G lesions of the colon and rectum

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age ≥ 18 years.
  • •Diagnosis of Laterally Spreading Tumor - Granular Type (LST-G) ≥ 20 mm in the colon or rectum with an indication for endoscopic resection.
  • •Life expectancy > 10 years.
  • •Ability to understand and sign the informed consent form, demonstrating comprehension of the study and willingness to participate.

排除标准

  • •Diagnosis of Laterally Spreading Tumor - Non-Granular Type (LST-NG).
  • •Presence of depressed areas within the lesion.
  • •Lesions located on a scar or anastomosis site.
  • •Lesions classified as Kudo Vi or Vn pattern.
  • •History of chronic inflammatory bowel disease (e.g., ulcerative colitis, Crohn's disease).
  • •Diagnosis of hereditary polyposis syndromes (e.g., familial adenomatous polyposis, Lynch syndrome).

研究组 & 干预措施

Endoscopic Mucosal Resection (EMR)

Active Comparator

干预措施: Endoscopic Mucosal Resection (EMR) (Procedure)

Endoscopic Submucosal Dissection (ESD)

Experimental

干预措施: Endoscopic Submucosal Dissection (ESD) (Procedure)

结局指标

主要结局

Recurrence/Adenomatous Residual Rate

时间窗: 6 and 12 months after treatment

Proportion of patients with local recurrence or residual adenomatous tissue, confirmed through follow-up colonoscopies and histopathological examination.

次要结局

  • Complete Resection Rate(6 and 12 months after treatment)
  • Differences in Procedure Time(Up to 2 months)
  • Bleeding Rate(During procedure (up to 2 months from enrollment) and 24 hours and 3 months after treatment)
  • Perforation Rate(During procedure (up to 2 months from enrollment) and 24 hours and 3 months after treatment)
  • Overall Complication Rate(24 hours after treatment)

研究者

发起方
Azienda USL Reggio Emilia - IRCCS
申办方类型
Other Gov
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验